Bayer's CEO Injects a Dose of U.S. Risk-Taking

Bayer’s CEO, Marijn Dekkers, is preparing to spin off the company’s $10 billion specialty-plastics business, part of an effort to refocus the company on health care and agriculture.



from WSJ.com: US Business http://ift.tt/1J1VoOZ

via IFTTT